Ariosto s. silva
Deparment of Cancer Imaging and Metabolism
Moffitt Cancer Center
United States of America
Dr. Ariosto S. Silva is affiliated to Deparment of Cancer Imaging and Metabolism, Moffitt Cancer Center. Dr. Ariosto S. Silva is currently providing services as Researcher. Dr. Ariosto S. Silva has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Ariosto S. Silva contributions have acclaimed recognition from honourable subject experts around the world. Dr. Ariosto S. Silva is actively associated with different societies and academies. Dr. Ariosto S. Silva academic career is decorated with several reputed awards and funding. Dr. Ariosto S. Silva research interests include Evolution of tumor invasiveness and adaptive tumor microenvironment particularly in multiple myeloma; cancer metabolism.
Evolution of tumor invasiveness and adaptive tumor microenvironment particularly in multiple myeloma; cancer metabolism
Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Nature Communications. 2017;8.
Emmons MF, Anreddy N, Cuevas J, Steinberger K, Yang S, McLaughlin M, Silva A, Hazlehurst LA. MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma. Scientific Reports. 2017;7.
Silva A, Silva MC, Sudalagunta P, Distler A, Jacobson T, Collins A, Nguyen T, Song J, Chen DT, Chen L, Cubitt C. An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma. Cancer Research. 2017 Jun 15;77(12):3336-51.